SCHEMBL13509497

SCHEMBL13509497

Cc1ccc(-c2ccc(CC(N)C(=O)O)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC7A5 Q01650 3/20 0.62
▸ PTGS1 P23219 3/20 0.61
▸ ALPI P09923 1/20 0.61
▸ PKM P14618 1/20 0.61
▸ XIAP P98170 1/20 0.61
▸ TPH1 P17752 5/20 0.61
▸ ALOX15 P16050 3/20 0.53
▸ HIF1A Q16665 3/20 0.53
▸ KDM4E B2RXH2 2/20 0.53
▸ TDP1 Q9NUW8 2/20 0.53
▸ USP2 O75604 1/20 0.53
▸ EGFR P00533 1/20 0.53
▸ LCK P06239 1/20 0.53
▸ FYN P06241 1/20 0.53
▸ ADORA3 P0DMS8 1/20 0.53
▸ HTR2A P28223 1/20 0.53
▸ PTGS2 P35354 1/20 0.53
▸ RECQL P46063 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ GRB2 P62993 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24424989 1.00 SLC7A5 (0.62) SLC7A5PTGS1ALPIPKMXIAP
Hydrochloric Acid SCHEMBL7307875 0.98 SLC7A5 (0.61) SLC7A5PTGS1ALPIPKMXIAP
Hydrochloric Acid SCHEMBL7307861 0.98 SLC7A5 (0.61) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL44872 0.94 SLC7A5 (0.69) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL192235 0.94 SLC7A5 (0.69) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL44871 0.94 SLC7A5 (0.69) SLC7A5PTGS1ALPIPKMXIAP
Hydrochloric Acid SCHEMBL3920419 0.93 SLC7A5 (0.67) SLC7A5PTGS1ALPIPKMXIAP
Hydrochloric Acid SCHEMBL3920413 0.93 SLC7A5 (0.67) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL156189 0.91 SLC7A5 (0.74) SLC7A5PTGS1ALPIPKMXIAP
SCHEMBL837014 0.91 SLC7A5 (0.74) SLC7A5PTGS1ALPIPKMXIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022103990-A1 METHODS OF MODIFYING PHOSPHORYLATED OR SULFATED TYROSINE RESIDUES OF POLYPEPTIDES PHOSFISH LLC (US) 2022-05-19 — — WO disclosed
US-20220144883-A1 METHODS OF MODIFYING PHOSPHORYLATED OR SULFATED TYROSINE RESIDUES OF POLYPEPTIDES PHOSFISH LLC 2022-05-12 — — US disclosed
US-7662572-B2 Compositions and liquid crystals PLATYPUS TECHNOLOGIES, LLC. (US) 2010-02-16 — — US disclosed
US-20070099249-A1 Compositions and liquid crystals PLATYPUS TECHNOLOGIES, LLC (US) 2007-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099249-A1 Compositions and liquid crystals FABP5, FABP1, SSB SLC7A5 661/4885PTGS1 4603/4885ALPI 1270/4885
US-20220144883-A1 METHODS OF MODIFYING PHOSPHORYLATED OR SULFATED TYROSINE RESIDUES OF POLYPEPTIDES PTMS, ACP1, SRMS SLC7A5 2697/4885PTGS1 4730/4885ALPI 3941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback